“…Although having more characters is preferable, we recognize that currently there are practical limits on the number of recording sites that can be incorporated into CRISPR-Cas9 systems. Current methods to incorporate recording sites into the genome (such as lentiviral transduction [3,10,12] or transposition [5,6,9,11,14]) are limited by the low uptake of these sites into the progenitor cell, only offering on the scale of tens of recording sites [10,6,5,12,3,9,8,7]. One alternate technology of particular interest is the baseeditor, which uses a modified Cas9 complex to induce direct base-pair substitutions [39].…”